298 related articles for article (PubMed ID: 31139630)
1. The Mechanisms by Which the Ketone Body D-β-Hydroxybutyrate May Improve the Multiple Cellular Pathologies of Parkinson's Disease.
Norwitz NG; Hu MT; Clarke K
Front Nutr; 2019; 6():63. PubMed ID: 31139630
[TBL] [Abstract][Full Text] [Related]
2. Increased Beta-Hydroxybutyrate Level Is Not Sufficient for the Neuroprotective Effect of Long-Term Ketogenic Diet in an Animal Model of Early Parkinson's Disease. Exploration of Brain and Liver Energy Metabolism Markers.
Kuter KZ; Olech Ł; Głowacka U; Paleczna M
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299176
[TBL] [Abstract][Full Text] [Related]
3. Ketotherapeutics for neurodegenerative diseases.
Norwitz NG; Jaramillo JG; Clarke K; Soto A
Int Rev Neurobiol; 2020; 155():141-168. PubMed ID: 32854853
[TBL] [Abstract][Full Text] [Related]
4. Beneficial Effects of Exogenous Ketogenic Supplements on Aging Processes and Age-Related Neurodegenerative Diseases.
Kovács Z; Brunner B; Ari C
Nutrients; 2021 Jun; 13(7):. PubMed ID: 34206738
[TBL] [Abstract][Full Text] [Related]
5. Molecular Mechanisms of Neuroprotection by Ketone Bodies and Ketogenic Diet in Cerebral Ischemia and Neurodegenerative Diseases.
Jang J; Kim SR; Lee JE; Lee S; Son HJ; Choe W; Yoon KS; Kim SS; Yeo EJ; Kang I
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203294
[TBL] [Abstract][Full Text] [Related]
6. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease.
Duan W; Mattson MP
J Neurosci Res; 1999 Jul; 57(2):195-206. PubMed ID: 10398297
[TBL] [Abstract][Full Text] [Related]
7. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.
Lindsay RM; Altar CA; Cedarbaum JM; Hyman C; Wiegand SJ
Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068
[TBL] [Abstract][Full Text] [Related]
8. KTX 0101: a potential metabolic approach to cytoprotection in major surgery and neurological disorders.
Smith SL; Heal DJ; Martin KF
CNS Drug Rev; 2005; 11(2):113-40. PubMed ID: 16007235
[TBL] [Abstract][Full Text] [Related]
9. Parkinson's Disease, the Dopaminergic Neuron and Gammahydroxybutyrate.
Mamelak M
Neurol Ther; 2018 Jun; 7(1):5-11. PubMed ID: 29368093
[TBL] [Abstract][Full Text] [Related]
10. New therapeutic strategy for Parkinson's and Alzheimer's disease.
Esposito E; Cuzzocrea S
Curr Med Chem; 2010; 17(25):2764-74. PubMed ID: 20586718
[TBL] [Abstract][Full Text] [Related]
11. Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Hirsch EC; Hunot S
Lancet Neurol; 2009 Apr; 8(4):382-97. PubMed ID: 19296921
[TBL] [Abstract][Full Text] [Related]
12. Why a d-β-hydroxybutyrate monoester?
Soto-Mota A; Norwitz NG; Clarke K
Biochem Soc Trans; 2020 Feb; 48(1):51-59. PubMed ID: 32096539
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's Disease and Photobiomodulation: Potential for Treatment.
Bicknell B; Liebert A; Herkes G
J Pers Med; 2024 Jan; 14(1):. PubMed ID: 38276234
[TBL] [Abstract][Full Text] [Related]
14. Parkinson's disease: Autoimmunity and neuroinflammation.
De Virgilio A; Greco A; Fabbrini G; Inghilleri M; Rizzo MI; Gallo A; Conte M; Rosato C; Ciniglio Appiani M; de Vincentiis M
Autoimmun Rev; 2016 Oct; 15(10):1005-11. PubMed ID: 27497913
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rb1 protects dopaminergic neurons from inflammatory injury induced by intranigral lipopolysaccharide injection.
Li DW; Zhou FZ; Sun XC; Li SC; Yang JB; Sun HH; Wang AH
Neural Regen Res; 2019 Oct; 14(10):1814-1822. PubMed ID: 31169200
[TBL] [Abstract][Full Text] [Related]
16. Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson's disease.
Cheng B; Yang X; An L; Gao B; Liu X; Liu S
Brain Res; 2009 Aug; 1286():25-31. PubMed ID: 19559687
[TBL] [Abstract][Full Text] [Related]
17. The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's disease.
Goulding SR; Sullivan AM; O'Keeffe GW; Collins LM
Neural Regen Res; 2020 Aug; 15(8):1432-1436. PubMed ID: 31997802
[TBL] [Abstract][Full Text] [Related]
18. [Applications and perspectives of ketone body D-β-hydroxybutyrate in the medical fields].
A L; Li Z; Lü J; Yu L; Situ W; Xue L; Wang H; Chen G
Sheng Wu Gong Cheng Xue Bao; 2022 Mar; 38(3):976-989. PubMed ID: 35355468
[TBL] [Abstract][Full Text] [Related]
19. Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction.
Ruppert MC; Greuel A; Tahmasian M; Schwartz F; Stürmer S; Maier F; Hammes J; Tittgemeyer M; Timmermann L; van Eimeren T; Drzezga A; Eggers C
Brain; 2020 Mar; 143(3):944-959. PubMed ID: 32057084
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
